Suchergebnisse - "Zhang, Hui-Lu"

PubPharm (30)

1

Ultrasensitive quantification of trace amines based on N-phosphorylation labeling chip 2D LC-QQQ/MS

enthalten in: Journal of pharmaceutical analysis | 2023

von Bian, X. | Zhang, Y. | Li, N. | +5

2

Phenylalanine impairs insulin signaling and inhibits glucose uptake through modification of IRβ

enthalten in: Nature communications | 2022

von Zhou, Q. | Sun, W. | Chen, J. | +14

3

Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2022

von Zhang, H. | Chen, P. | Yan, H. | +14

4

Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway

enthalten in: Oncogenesis | 2021

von Wang, M. | Wang, N. | Zhang, H. | +7

5

Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2

enthalten in: Cancer letters | 2018

von Qin, C. | Zhao, L. | Zhou, X. | +13

6

Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice

enthalten in: Hepatology (Baltimore, Md.) | 2017

von Hou, G. | Chen, L. | Liu, G. | +19

7

Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment

enthalten in: Cancer letters | 2017

von Zhang, H. | Wang, M. | Zhou, X. | +13

8

Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment

enthalten in: Cancer letters | 2017

von Zhang, H. | Wang, M. | Zhou, X. | +13

9

Aldehyde dehydrogenase‐2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP‐activated protein kinase signaling in mice

enthalten in: Hepatology | 2017

von Hou, G. | Chen, L. | Liu, G. | +19

10

Erratum : Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma

enthalten in: Nature communications | 2016

von Zhao, L. | Liu, X. | Yan, H. | +38

ErratumFor: Nat Commun. 2016 Oct 05;7:12992. - PMID 27703150